Alibaba Health Information Technology Ltd

00241

Company Profile

  • Business description

    Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer”, although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

  • Contact

    Guanghua Road
    65th Floor, CITIC Tower, Building 1, No.10 Courtyard
    Jianwai Subdistrict, Chaoyang District
    Beijing
    CHN

    https://www.alihealth.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    1,422

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,524.30323.30-4.12%
CAC 406,927.12347.83-4.78%
DAX 4019,789.62852.10-4.13%
Dow JONES (US)37,861.322,684.61-6.62%
FTSE 1007,702.08352.90-4.38%
HKSE19,828.303,021.51-13.22%
NASDAQ15,520.921,029.69-6.22%
Nikkei 22531,136.582,644.00-7.83%
NZX 50 Index11,775.88449.40-3.68%
S&P 5005,044.1429.94-0.59%
S&P/ASX 2007,343.30324.50-4.23%
SSE Composite Index3,096.58245.43-7.34%

Market Movers